Displaying 1–20 of 33 in total
Living with a Familial Risk of Pancreatic Cancer
Pancreatic cancer took Andy Lyons’ grandmother, mother, aunt, uncle, and brother. Could he prevent it from becoming his story, too? Host Alisyn Camerota sits down with...
PNET Treatment and Survival
In this episode of PancChat, host Alisyn Camerota is joined by pancreatic neuroendocrine tumor, or PNET, patient Katie DeCarlo. Katie shares her experience living with...
Managing Pancreatic Neuroendocrine Tumors
Not all pancreatic cancers are the same. While most patients are diagnosed with pancreatic adenocarcinoma, approximately 10% have pancreatic neuroendocrine tumors (PNE...
The KRAS Mutation
Up to 95% of pancreatic cancer patients have a KRAS mutation in their tumor. For decades, it was considered impossible to target with a drug. What changed? To get the ...
Rasonque™: A New Drug for Pancreatic Cancer
The U.S. Food & Drug Administration (FDA) just approved a treatment that doubled survival time for patients with metastatic pancreatic cancer — what does this landmark...
Managing Diabetes During Pancreatic Cancer Treatment
Diabetes and pancreatic cancer often go hand in hand. Between 30 to 50% of patients have diabetes or prediabetes at diagnosis, and another 40% develop it during treatm...
The Link Between Diabetes and Pancreatic Cancer
Almost one in four people diagnosed with pancreatic cancer are also diagnosed with diabetes. In this episode of PancChat, host Alisyn Camerota talks with Dr. Suresh Ch...
Emerging Trials in Pancreatic Cancer
With one new drug against the KRAS mutation on the path to FDA approval, what is the status of other KRAS drugs, as well as different types of treatment? To get the ...
Pancreatic Cancer Advancements This Year
New pancreatic cancer treatments have not been approved in many years, but the first half of 2026 has seen some significant treatment advances. In this episode, host A...
Surviving Pancreatic Cancer
Roberta Luna is a 24-year pancreatic cancer survivor. When she was diagnosed in 2002, her doctors gave her months to live. But she was determined that the same diseas...
Living with Pancreatic Cancer
What is it like to live with pancreatic cancer?. Randi Ervin was diagnosed with a pancreatic neuroendocrine tumor (PNET) in her 30s. Even after a total pancreatectomy...
AI and Early Detection of Pancreatic Cancer
What if artificial intelligence could catch pancreatic cancer before a radiologist's eye does? In this episode of PancChat, host Alisyn Camerota speaks with Dr. Ellio...
Pancreatic Cancer Screening and Surveillance
Pancreatic cancer is most often caught late — but that is starting to change. In this episode of PancChat, host Alisyn Camerota sits down with Dr. Raymond Wadlow, a ga...
Immunotherapy and Personalized Treatments
So far, immunotherapy has been a game-changer in other cancers but not pancreatic cancer. Is that finally changing? In this episode of PancChat, host Alisyn Camerota s...
Pancreatic Cancer Vaccines
In this episode of PancChat, host Alisyn Camerota sits down with Dr. Vinod Balachandran, a surgeon-scientist at Memorial Sloan Kettering Cancer Center and the founding...
Pancreatic Enzyme Replacement Therapy
Pancreatic enzyme replacement therapy — known as PERT — may be one of the most important yet overlooked tools for pancreatic cancer patients and survivors. In this ep...
Nutrition for Pancreatic Cancer Patients
Eating during pancreatic cancer treatment can be challenging. In this episode, PancChat host Alisyn Camerota sits down with Audrey Caspar-Clark, an outpatient oncology...
Pancreatic Cancer Research -- Where We Are Going
What's on the horizon for pancreatic cancer treatment and earlier detection? In this episode, host Alisyn Camerota sits down with Dr. Andrew Ko, professor of medicine ...
Pancreatic Cancer Research -- Where We Are Now
Where does pancreatic cancer research stand today — and what does it mean for patients and families right now? In this episode, host Alisyn Camerota sits down with Dr....
Demystifying Clinical Trials Part 2: Barriers
In this continuation of our conversation about clinical trials, host Alisyn Camerota and Martin D Hynes, III, discuss the real obstacles patients face when pursuing c...